Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/52917

language	eng
Author	Ono, Ruriko Department of Obstetrics and Gynecology, Shimane University School of Medicine, 6938501 Izumo, Japan NAKAYAMA, Kentaro NAKAMURA, Kohei YAMASHITA, Hitomi ISHIBASHI, Tomoka ISHIKAWA, Masako MINAMOTO, Toshiko Razia Sultana Department of Obstetrics and Gynecology, Shimane University School of Medicine, 6938501 Izumo, Japan ISHIKAWA, Noriyoshi Otsuki, Yoshiro Department of Pathology, Seirei Hamamatsu General Hospital, 4308558 Hamamatsu, Japan Nakayama , Satoru Department of Obstetrics and Gynecology, Seirei Hamamatsu General Hospital, 4308558 Hamamatsu, Japan Onuma, Hideyuki Department of Pathology, Shimane Prefectural Central Hospital, 6938555 Izumo, Japan Kurioka, Hiroko Department of Obstetrics and Gynecology, Shimane Prefectural Central Hospital, 6938555 Izumo, Japan KYO, Satoru
Subject	dedifferentiated endometrial carcinoma; mismatch repair deficient; microsatellite instability; endometrial cancer; immune checkpoint inhibitor
Journal Title	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume	20
Issue	15
ISSN（Online）	1422-0067
Published Date	2019-08
DOI	10.3390/ijms20153744
PubMed ID	31370215
Publisher	MDPI
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	This research was funded by grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (18K09229).